Genome engineering is a collection of biomedical techniques that can be used to modify the bases of DNA in an organism. It has been used for decades to modify the genomes of many organisms and some mammals. Gene therapy is divided into two types, ex-vivo gene therapy and in-vivo gene therapy. In Ex-Vivo gene therapy, genes are transferred into cultured cells and then reintroduced into the patient. Whereas in-vivo gene therapy involves the direct introduction of genes into cells of a specific tissue. There are many advanced tools for genetic engineering that make it possible to modify genomes by adding and modifying sections of DNA sequences. CRISPR, one of the techniques used for DNA editing, is faster, more precise and economical compared to other techniques.
Get Your FREE Copy of The 2021 Genome Engineering Market Report
The introduction of new technologies in genome engineering by market players is expected to increase the genome engineering market growth during the forecast period. For example, in February 2018, Sangamo announced the UK authorization of a clinical trial evaluating the in vivo editing treatment of zinc finger nuclease for hemophilia B. Additionally, in July 2017, Integrated DNA Technologies (IDT) announced the launch of the first variant of the Cas9 enzyme that dramatically reduces off-target effects in CRISPR genome editing without compromising activity on the target. Additionally, in December 2017, Salk scientists created a new version of CRISPR / Cas9 genome editing technology that allows them to activate genes without creating breaks in DNA, potentially bypassing a hurdle. major in the use of gene editing technologies to treat human diseases.
In addition, market players are adopting various inorganic strategies, such as collaboration and partnership, to strengthen their product portfolio, as well as to strengthen their position in the market. This in turn is expected to drive the growth of the global genome engineering market. For example, in February 2018, Kite Pharma and Sangamo Therapeutics collaborated to develop modified cell therapies to treat cancer. Likewise, in 2017, Synthego collaborated with Thermo Fisher to manufacture and distribute synthetic guide RNA products for CRISPR genome engineering.
Request Sample PDF Copy of Genome Engineering Market Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1262
In addition, the increase in the development of research for new technologies is also expected to drive the growth of the global genome engineering market. For example, in 2018, the US National Institutes of Health (NIH) invested approximately US $ 190 million in genome editing research.
The high cost associated with the development of new genomic engineering technologies is expected to hamper the growth of the global genomic engineering market during the forecast period. Moreover, genome engineering is a very complex technology and requires highly skilled researchers which is also expected to hamper the growth of the market.
- Cell line engineering
- Genetic engineering
By end user:
- Biotech and pharmaceutical companies
- Research institutes
- Contract research organizations
- North America
- Latin America
- Asia Pacific
- Middle East and Africa
Buy this premium report now to grow your business: https://www.coherentmarketinsights.com/insight/buy-now/1262
Reasons to buy this report
• Current and future outlook of the global genome engineering market in developed and emerging markets
• The segment which is expected to dominate the market as well as the segment which holds the highest CAGR during the forecast period.
• Regions / countries expected to experience the fastest growth rates during the forecast period
• The latest developments, market shares and strategies used by the main market players
“Limited time offer”
Access an in-depth study with over 150 pages, a list of tables and figures, profiling over 20 companies.
We also offer 15% FREE customization of reports.
Get this premium report with an instant discount of US $ 2000 @ https://www.coherentmarketinsights.com/promo/buynow/1262
The major players operating in the genomic engineering market are Merck Group, Cellectis SA, Bluebird Bio, Inc., Sangamo Therapeutics, Inc., Editas Medicine, Inc., Intellia Therapeutics, Inc., CRISPR Therapeutics AG and Thermo Fisher Scientific Inc.
Global Genome Engineering Market Research Report
Section 1: Overview of the Global Genome Engineering Industry
Section 2: Global Economic Impact on the Genome Engineering Industry
Section 3: Competition in the world market by industry producers
Section 4: World Productions, Revenue (Value), by Region
Section 5: Global Supply (Production), Consumption, Export, Import, Geographically
Section 6: World Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, Based on Application
Section 8: Genome Engineering Market Price Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Key Distributor / Supplier / Dealer Strategies and Policies
Section 11: Analysis of Key Marketing Strategy, by Market Suppliers
Section 12: Analysis of Market Effect Factors
Section 13: Global Genome Engineering Market Forecast
Other exclusive reports:
Regenerative Medicine Market (Bones & Joints)
Life Sciences Products Market
Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients of all backgrounds, from Fortune 500 companies to nonprofits and startups looking to enter the market. We excel in providing unmatched actionable market insights across various industry verticals including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.
To learn more about us, please visit our website – www.coherentmarketinsights.com
Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837
See the press release for more information